Reaction

Splenic Lesion reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 363 reports · 5 co-occurring drugs

As of the last recalculation, Splenic Lesion appears in 363 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is FEBUXOSTAT TABLETS 40 MG (PRR 82.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Febuxostat Tablets 40 Mg1482.182.2
Febuxostat Tablets 80 Mg1482.182.2
Febuxostat1449.849.8
Axicabtagene Ciloleucel741.541.5
Pazopanib Hydrochloride1328.528.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.